-
1
-
-
0032703485
-
Epidémiologie, prise en charge et coût du diabète de type 2 en France en 1998
-
Detournay B, Vauzelle-Kervroedan F, Charles MA, et al. Epidémiologie, prise en charge et coût du diabète de type 2 en France en 1998. Diabetes Metab, 1999, 25, 356-65.
-
(1999)
Diabetes Metab
, vol.25
, pp. 356-365
-
-
Detournay, B.1
Vauzelle-Kervroedan, F.2
Charles, M.A.3
-
2
-
-
0033948880
-
Stratégie de la prise en charge du patient diabétique de type II à l'exclusion de la prise en charge des complications
-
ANAES. Stratégie de la prise en charge du patient diabétique de type II à l'exclusion de la prise en charge des complications. Diabetes Metab. 2000, 26, 232-43.
-
(2000)
Diabetes Metab
, vol.26
, pp. 232-243
-
-
-
5
-
-
0033670847
-
Managing type 2 diabetes in France: The ECODIA survey
-
Detournay B, Cros S, Charbonnel B, et al. Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab, 2000, 26, 363-9.
-
(2000)
Diabetes Metab
, vol.26
, pp. 363-369
-
-
Detournay, B.1
Cros, S.2
Charbonnel, B.3
-
6
-
-
0031960919
-
Low prevalence of long term complications in non insulin dependent diabetes mellitus in France: A multicenter study
-
Delcourt C, Vauzelle-Kervroedan F, Cathelineau G, Papoz L, the CODIAB-INSERM-ZENECA Pharma Study Group. Low prevalence of long term complications in non insulin dependent diabetes mellitus in France: a multicenter study. J Diabetes Complications, 1998, 12, 88-95.
-
(1998)
J Diabetes Complications
, vol.12
, pp. 88-95
-
-
Delcourt, C.1
Vauzelle-Kervroedan, F.2
Cathelineau, G.3
Papoz, L.4
-
7
-
-
0033663743
-
Epidemiological analysis of patients with Type 2 diabetes in France
-
Grimaldi A, Grangé V, Allanic H, et al. Epidemiological analysis of patients with Type 2 diabetes in France. J Diabetes Complications, 2000, 14, 242-9.
-
(2000)
J Diabetes Complications
, vol.14
, pp. 242-249
-
-
Grimaldi, A.1
Grangé, V.2
Allanic, H.3
-
8
-
-
0028593333
-
Estimation of CHD risk in a French working population using a modified Framingham model
-
The PCV-METRA Group
-
Laurier D, Nguyen PC, Cazelles B, Segond P. Estimation of CHD risk in a French working population using a modified Framingham model. The PCV-METRA Group. J Clin Epidemiol, 1994, 47, 1353-64.
-
(1994)
J Clin Epidemiol
, vol.47
, pp. 1353-1364
-
-
Laurier, D.1
Nguyen, P.C.2
Cazelles, B.3
Segond, P.4
-
9
-
-
0031470358
-
Managing the burden of type 2 diabetes: An international survey of physicians
-
Southwell A, Eckland D. Managing the burden of type 2 diabetes: an international survey of physicians. Pract Diabetes Int, 1997, 14,201-6.
-
(1997)
Pract Diabetes Int
, vol.14
, pp. 201-206
-
-
Southwell, A.1
Eckland, D.2
-
10
-
-
0035658119
-
Effects of clinical audit on the quality of care in patients with type 2 diabetes: Results of the DIABEST pilot study
-
Varroud-Vial M, Charpentier G, Vaur L, et al. Effects of clinical audit on the quality of care in patients with type 2 diabetes: Results of the DIABEST pilot study. Diabetes Metab, 2001, 27, 666-74.
-
(2001)
Diabetes Metab
, vol.27
, pp. 666-674
-
-
Varroud-Vial, M.1
Charpentier, G.2
Vaur, L.3
-
11
-
-
4243254289
-
Des écarts significatifs persistent entre le traitement des patients atteints de diabète de type 2 et les Recommandations de Pratique Clinique
-
abstract
-
Varroud-Vial M, Attali C, Attali JR, et al. Des écarts significatifs persistent entre le traitement des patients atteints de diabète de type 2 et les Recommandations de Pratique Clinique. [abstract] Diabetes Metab, 2002, 28, IS24.
-
(2002)
Diabetes Metab
, vol.28
-
-
Varroud-Vial, M.1
Attali, C.2
Attali, J.R.3
-
12
-
-
0032511583
-
Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352, 837-53.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
13
-
-
0034641568
-
Epidemiological association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35)
-
Stratton IM, Adler AI, Neil HAW. Matthews DR, Manley SE, Cull CA, et al. Epidemiological association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ, 2000, 321, 405-12.
-
(2000)
BMJ
, vol.321
, pp. 405-412
-
-
Stratton, I.M.1
Adler, A.I.2
Neil, H.A.W.3
Matthews, D.R.4
Manley, S.E.5
Cull, C.A.6
-
14
-
-
0032511580
-
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
-
UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ, 1998, 317, 703-13.
-
(1998)
BMJ
, vol.317
, pp. 703-713
-
-
-
15
-
-
0034641550
-
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
-
Adler AI, Stratton IM, Neil HAW, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ, 2000, 321, 412-9.
-
(2000)
BMJ
, vol.321
, pp. 412-419
-
-
Adler, A.I.1
Stratton, I.M.2
Neil, H.A.W.3
-
16
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet, 1998, 351, 1755-62.
-
(1998)
Lancet
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
|